Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3

NCT05264584 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05264584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05264584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2020
Completion date
February 1, 2022
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease stage3, contrast-induced nephropathy